These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 10650154)
1. The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats. Haapalinna A; Sirviö J; MacDonald E; Virtanen R; Heinonen E Eur J Pharmacol; 2000 Jan; 387(2):141-50. PubMed ID: 10650154 [TBL] [Abstract][Full Text] [Related]
2. Facilitation of cognitive functions by a specific alpha2-adrenoceptor antagonist, atipamezole. Haapalinna A; Sirviö J; Lammintausta R Eur J Pharmacol; 1998 Apr; 347(1):29-40. PubMed ID: 9650845 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036 [TBL] [Abstract][Full Text] [Related]
4. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats. Haapalinna A; Leino T; Heinonen E Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451 [TBL] [Abstract][Full Text] [Related]
5. The effects of alpha-2 adrenoceptor antagonist, atipamezole, on spatial learning in scopolamine-treated and aged rats. Sirviö J; Riekkinen P; MacDonald E; Airaksinen M; Lammintausta R; Riekkinen PJ J Neural Transm Park Dis Dement Sect; 1992; 4(2):99-106. PubMed ID: 1349212 [TBL] [Abstract][Full Text] [Related]
6. The effects of ethanol in combination with the alpha 2-adrenoceptor agonist dexmedetomidine and the alpha 2-adrenoceptor antagonist atipamezole on brain monoamine metabolites and motor performance of mice. Idänpään-Heikkilä JJ; Björn M; Seppälä T Eur J Pharmacol; 1995 Jan; 292(2):191-9. PubMed ID: 7536679 [TBL] [Abstract][Full Text] [Related]
8. Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents. Chopin P; Colpaert FC; Marien M J Pharmacol Exp Ther; 2002 Apr; 301(1):187-96. PubMed ID: 11907173 [TBL] [Abstract][Full Text] [Related]
9. Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats. Jolkkonen J; Puurunen K; Rantakömi S; Härkönen A; Haapalinna A; Sivenius J Eur J Pharmacol; 2000 Jul; 400(2-3):211-9. PubMed ID: 10988336 [TBL] [Abstract][Full Text] [Related]
10. Effects of a selective alpha 2-adrenoceptor antagonist, atipamezole, on hypothalamic histamine and noradrenaline release in vivo. Laitinen KS; Tuomisto L; MacDonald E Eur J Pharmacol; 1995 Oct; 285(3):255-60. PubMed ID: 8575511 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of alpha-2 receptor agents and THA on the performance of adult and aged rats in the delayed non-matching to position task. Sirviö J; Harju M; Riekkinen P; Haapalinna A; Riekkinen PJ Psychopharmacology (Berl); 1992; 109(1-2):127-33. PubMed ID: 1365646 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats. Haapalinna A; MacDonald E; Viitamaa T; Salonen JS; Sirviö J; Virtanen R Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):194-203. PubMed ID: 10208306 [TBL] [Abstract][Full Text] [Related]
13. The effects of atipamezole, an alpha-2 antagonist, on the performance of young and aged rats in the delayed nonmatching to position task. Sirviö J; Lukkarinen K; Riekkinen P; Koivisto E; Virtanen R; Pennanen A; Valjakka A; Riekkinen PJ Pharmacol Biochem Behav; 1991 Aug; 39(4):1015-9. PubMed ID: 1684866 [TBL] [Abstract][Full Text] [Related]
14. Systemic administration of atipamezole, an alpha 2-antagonist, can reduce scopolamine-induced hyperactivity in rats. Niittykoski M; Hakkarainen V; Puumala T; Lappalainen R; Ruotsalainen S; Haapalinna A; Sirviö J Behav Pharmacol; 1997 Oct; 8(5):465-70. PubMed ID: 9832985 [TBL] [Abstract][Full Text] [Related]
15. Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative. MacDonald E; Scheinin H; Scheinin M Eur J Pharmacol; 1988 Dec; 158(1-2):119-27. PubMed ID: 2906007 [TBL] [Abstract][Full Text] [Related]
16. Systemic administration of atipamezole, a selective antagonist of alpha-2 adrenoceptors, facilitates behavioural activity but does not influence short-term or long-term memory in trimethyltin-intoxicated and control rats. Niittykoski M; Lappalainen R; Jolkkonen J; Haapalinna A; Riekkinen P; Sirviö J Neurosci Biobehav Rev; 1998 Oct; 22(6):735-50. PubMed ID: 9809309 [TBL] [Abstract][Full Text] [Related]
17. Behavioural and neurochemical effects of antipamezole, a novel alpha 2-adrenoceptor antagonist. Scheinin H; MacDonald E; Scheinin M Eur J Pharmacol; 1988 Jun; 151(1):35-42. PubMed ID: 2901363 [TBL] [Abstract][Full Text] [Related]
18. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Lapiz MD; Morilak DA Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081 [TBL] [Abstract][Full Text] [Related]
19. Effects of atipamezole, an alpha 2-adrenoceptor antagonist, on the performance of rats in a five-choice serial reaction time task. Jäkälä P; Sirviö J; Riekkinen P; Haapalanna A; Riekkinen P Pharmacol Biochem Behav; 1992 Aug; 42(4):903-7. PubMed ID: 1355298 [TBL] [Abstract][Full Text] [Related]